dilazep has been researched along with Central Nervous System Origin Vertigo in 1 studies
Dilazep: Coronary vasodilator with some antiarrhythmic activity.
dilazep : A member of the class of diazepanes that is 1,4-diazepane substituted by 3-[(3,4,5-trimethoxybenzoyl)oxy]propyl groups at positions 1 and 4. It is a potent adenosine uptake inhibitor that exhibits antiplatelet, antianginal and vasodilator properties.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with vertebrobasilar insufficiency tend to develop transient, repeated vertigo." | 1.30 | Vertigo secondary to hypotension: the relationship between therapeutic effects and hearing. ( Ito, F; Kamada, H; Tanaka, K, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, F | 1 |
| Tanaka, K | 1 |
| Kamada, H | 1 |
1 other study available for dilazep and Central Nervous System Origin Vertigo
| Article | Year |
|---|---|
Vertigo secondary to hypotension: the relationship between therapeutic effects and hearing.
Topics: Adenosine Triphosphate; Adult; Aged; Audiometry, Pure-Tone; Diagnosis, Differential; Dilazep; Drug T | 1998 |